364
Views
10
CrossRef citations to date
0
Altmetric
CONTRACEPTION

Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?

, , , , , , , , , & show all
Pages 1090-1095 | Received 16 Jan 2020, Accepted 13 Apr 2020, Published online: 02 May 2020

References

  • Weenen C, Laven JSE, von BA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.
  • Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95(1):170–175.
  • Freeman EW, Sammel MD, Lin H, et al. Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97(5):1673–1680.
  • Depmann M, Eijkemans MJC, Broer SL, et al. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Hum Reprod. 2016;31(7):1580–1587.
  • Broer SL, Eijkemans MJC, Scheffer GJ, et al. Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532–2539.
  • La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124–140.
  • Tremellen K, Savulescu J. Ovarian reserve screening: a scientific and ethical analysis. Hum Reprod. 2014;29(12):2606–2614.
  • Bavan B, Porzig E, Baker VL. An assessment of female university students’ attitudes toward screening technologies for ovarian reserve. Fertil Steril. 2011;96(5):1195–1199.
  • Hvidman HW, Petersen KB, Larsen EC, et al. Nyboe Andersen A. Individual fertility assessment and pro-fertility counselling; should this be offered to women and men of reproductive age? Hum Reprod. 2015;30(1):9–15.
  • Birch Petersen K, Maltesen T, Forman JL, et al. The fertility assessment and counseling clinic – does the concept work? A prospective 2-year follow-up study of 519 women. Acta Obstet Gynecol Scand. 2017;96(3):313–325.
  • Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30(10):2364–2375.
  • Bentzen JG, Forman JL, Pinborg A, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online. 2012;25(6):612–619.
  • Kallio S, Puurunen J, Ruokonen A, et al. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil Steril. 2013;99(5):1305–1310.
  • Kallio S, Puurunen J, Ruokonen A, et al. Anti-Müllerian hormone as a marker of follicular inhibition by combined contraception – a randomized study. Fertil Steril. 2012; 99(5):1305–1310.
  • Goldzieher JW, Pena A, Chenault CB, et al. Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency. Am J Obstet Gynecol. 1975;122(5):619–624.
  • Mishell DR, Kletzky OA, Brenner PF, et al. The effect of contraceptive steroids on hypothalamic-pituitary function. Am J Obstet Gynecol. 1977;128(1):60–74.
  • Frederiksen H, Johannsen TH, Andersen SE, et al. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. J Clin Endocrinol Metab. 2019;105(3): pii: dgz196.
  • Van Heusden AM, Fauser B. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception. 1999;59(4):237–243.
  • Amiri M, Ramezani Tehrani F, Nahidi F, et al. Comparing the effects of combined oral contraceptives containing progestins with low androgenic and antiandrogenic activities on the hypothalamic-pituitary-gonadal axis in patients with polycystic ovary syndrome: systematic review and meta-analysis. JMIR Res Protoc. 2018;7(4):e113.
  • Amiri M, Nahidi F, Bidhendi-Yarandi R, et al. A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial. Hum Reprod. 2020;35(1):175–186.
  • Landersoe SK, Forman JL, Birch Petersen K, et al. Ovarian reserve markers in women using various hormonal contraceptives. Eur J Contracept Reprod Health Care. 2020;25(1):65–71.
  • Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77(3):162–170.
  • Bentzen JG, Forman JL, Johannsen TH, et al. Ovarian antral follicle subclasses and anti-Müllerian hormone during normal reproductive aging. J Clin Endocrinol Metab. 2013;98(4):1602–1611.
  • Rosendahl M, Ernst E, Rasmussen PE, et al. True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement. Fertil Steril. 2010;93(3):995–998.
  • Anckaert E, Öktem M, Thies A, et al. Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination. Clin Biochem. 2016;49(3):260–267.
  • Biochemestry RD of. Method list, Department of Biochemestry, Rigshospitalet. http://metodeliste.rh.dk/Labportal.asp?ShowStart=Y
  • R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2018. R Foundation for Statistical Computing. R Found Stat Comput Vienna, Austria. 2018. doi:ISBN 3-900051-07-0
  • Benjamini Y, Hochberg Y. Controlling the FDR: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289–300.
  • Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519–527.
  • Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009;30(6):624–712.
  • Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 47–51.
  • Hyldgaard J, Bor P, Ingerslev HJ, et al. Comparison of two different methods for measuring anti-Mullerian hormone in a clinical series. Reprod Biol Endocrinol. 2015;13(1):107.
  • Rustamov O, Smith A, Roberts SA, et al. The measurement of anti-Müllerian hormone: a critical appraisal. J Clin Endocrinol Metab. 2014;99(3):723–732.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.